Abstract
This study aimed to analyze the protective effects of photobiomodulation therapy (PBMT) with combination of low-level laser therapy (LLLT) and light emitting diode therapy (LEDT) on skeletal muscle tissue to delay dystrophy progression in mdx mice (DMDmdx). To this aim, mice were randomly divided into five different experimental groups: wild type (WT), placebo-control (DMDmdx), PBMT with doses of 1 J (DMDmdx), 3 J (DMDmdx), and 10 J (DMDmdx). PBMT was performed employing a cluster probe with 9 diodes (1 x 905nm super-pulsed laser diode; 4 x 875nm infrared LEDs; and 4 x 640nm red LEDs, manufactured by Multi Radiance Medical®, Solon - OH, USA), 3 times a week for 14 weeks. PBMT was applied on a single point (tibialis anterior muscle—bilaterally). We analyzed functional performance, muscle morphology, and gene and protein expression of dystrophin. PBMT with a 10 J dose significantly improved (p < 0.001) functional performance compared to all other experimental groups. Muscle morphology was improved by all PBMT doses, with better outcomes with the 3 and 10 J doses. Gene expression of dystrophin was significantly increased with 3 J (p < 0.01) and 10 J (p < 0.01) doses when compared to placebo-control group. Regarding protein expression of dystrophin, 3 J (p < 0.001) and 10 J (p < 0.05) doses also significantly showed increase compared to placebo-control group. We conclude that PBMT can mainly preserve muscle morphology and improve muscular function of mdx mice through modulation of gene and protein expression of dystrophin. Furthermore, since PBMT is a non-pharmacological treatment which does not present side effects and is easy to handle, it can be seen as a promising tool for treating Duchenne’s muscular dystrophy.
Similar content being viewed by others
References
Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette NA (2016) Systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163–177
Macedo AB, Moraes LHR, Mizobuti DS, Fogaça AR, Moraes FSR, Hermes TA et al (2015) Low-level laser therapy (LLLT) in dystrophin-deficient muscle cells: effects on regeneration capacity, inflammation response and oxidative stress. PLoS One 10(6):e0128567
Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, Jain M, Kleijnen J (2017) The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Diseases 12(1):79
Fayssoil A, Abasse S, Silverston K (2017) Cardiac involvement classification and therapeutic Management in Patients with Duchenne muscular dystrophy. J Neuromuscul Dis 4(1):17–23
Pane M, Pane M, Scalise R, Berardinelli A, D'Angelo G, Ricotti V, Alfieri P, Moroni I, Hartley L, Pera MC, Baranello G, Catteruccia M, Casalino T, Romeo DM, Graziano A, Gandioli C, Bianco F, Mazzone ES, Lombardo ME, Scoto M, Sivo S, Palermo C, Gualandi F, Sormani MP, Ferlini A, Bertini E, Muntoni F, Mercuri E (2013) Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul Disord 23:451–455
Wu B, Cloer C, Lu P, Milazi S, Shaban M, Shah SN, Marston-Poe L, Moulton HM, QL L (2014) Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice. Gene Ther 21:785–793
Falzarano M, Scotton C, Passarelli C, Ferlini A (2015) Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20:18168–18184
Gouveia TL, Kossugue PM, Paim JF, Zatz M, Anderson LV, Nigro V, Vainzof M (2007) A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of δ-sG protein. J Mol Med 85:415–420
Allen DG, Whitehead NP, Froehner SC (2015) Absence of dystrophin disrupts skeletal muscle signaling: roles of ca 2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev 96:223–305
Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 4(1):67–76
Salam EA, Meguid IA, Korraa S (2007) Markers of oxidative stress and aging in Duchene muscular dystrophy patients and the possible ameliorating effect of he:ne laser. Acta Myologica 26:14–21
McGreevy JW, Hakim CH, McIntosh MA, Duan D (2015) Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech 8:195–213
Serra F, Quarta M, Canato M, Toniolo L, De Arcangelis V, Trotta A, Spath L, Monaco L, Reggiani C, Naro F (2012) Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve 46:773–784
Angelini C (2007) The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 36:424–435
Lim KRQ, Maruyama R, Yokota T (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther 11:533–545
Santos LA, Marcos RL, Tomazoni SS, Vanin AA, Antonialli FC, Grandinetti Vdos S, Albuquerque-Pontes GM, de Paiva PR, Lopes-Martins RÁ, de Carvalho Pde T, Bjordal JM, Leal-Junior EC (2014) Effects of pre-irradiation of low-level laser therapy with different doses and wavelengths in skeletal muscle performance, fatigue, and skeletal muscle damage induced by tetanic contractions in rats. Lasers Med Sci 29:1617–1626
Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT (2004) Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 4:559–567
Gonzalez-Lima F, Barksdale BR, Rojas JC (2014) Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol 88:584–593
Rojas JC, Gonzalez-Lima F (2013) Neurological and psychological applications of transcranial lasers and LEDs. Biochem Pharmacol 86:447–457
Avni D, Levkovitz S, Maltz OU (2005) Protection of skeletal muscles from ischemic injury: low-level laser therapy increases antioxidant activity. Photomed Laser Surg 23:273–277
Rizzi CF, Mauriz JL, Freitas Corrêa DS, Moreira AJ, Zettler CG, Filippin LI, Marroni NP, González-Gallego J (2006) Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-κB signaling pathway in traumatized muscle. Lasers Surg Med 38:704–713
Leal-Junior EC, Vanin AA, Miranda EF, de Carvalho Pde T, Dal Corso S, Bjordal JM (2015) Effect of phototherapy (low-level laser therapy and light-emitting diode therapy) on exercise performance and markers of exercise recovery: a systematic review with meta-analysis. Lasers Med Sci 30:925–939
Vanin AA, Verhagen E, Barboza SD, Costa LOP, Leal-Junior ECP (2017) Photobiomodulation therapy for the improvement of muscular performance and reduction of muscular fatigue associated with exercise in healthy people: a systematic review and meta-analysis. Lasers Med Sci. https://doi.org/10.1007/s10103-017-2368-6
Albuquerque-Pontes GM, Vieira RP, Tomazoni SS, Caires CO, Nemeth V, Vanin AA, Santos LA, Pinto HD, Marcos RL, Bjordal JM, de Carvalho Pde T, Leal-Junior EC (2015) Effect of pre-irradiation with different doses, wavelengths, and application intervals of low-level laser therapy on cytochrome c oxidase activity in intact skeletal muscle of rats. Lasers Med Sci 30:59–66
Leal-Junior EC, de Almeida P, Tomazoni SS, de Carvalho PT, Lopes-Martins RÁ, Frigo L, Joensen J, Johnson MI, Bjordal JM (2014) Superpulsed low-level laser therapy protects skeletal muscle of mdx mice against damage, inflammation and morphological changes delaying dystrophy progression. PLoS One 9(3):e89453
Silva AA, Leal-Junior EC, D'Avila Kde A, Serra AJ, Albertini R, França CM, Nishida JA, de Carvalho Pde T (2015) Pre-exercise low-level laser therapy improves performance and levels of oxidative stress markers in mdx mice subjected to muscle fatigue by high-intensity exercise. Lasers Med Sci 30:1719–1727
Nakamura A, Takeda S (2011) Mammalian models of Duchenne muscular dystrophy: pathological characteristics and therapeutic applications. J Biomed Biotechnol 2011:184393
MacLennan PA, Edwards RH (1990) Proteinturnover is elevated in muscle of mdx mice in vivo. Biochem J 268(3):795–797
Alderton JM, Steinhardt RA (2000) How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic Myotubes. Trends Cardiovasc Med 10:268–272
Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23:1456–1471
Shefer G, Barash I, Oron U, Halevy O (2003) Low-energy laser irradiation enhances de novo protein synthesis via its effects on translation-regulatory proteins in skeletal muscle myoblasts. Biochim Biophys Acta 1593:131–139
Luz MAM, Marques MJ, Santo Neto H (2002) Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res 35:691–695
Rahimov F, Kunkel LM (2013) Cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol 201:499–510
Onofre-Oliveira PCG, Santos ALF, Martins PM, Ayub-Guerrieri D, Vainzof M (2012) Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies. NeuroMolecular Med 14:74–83
Gumerson JD, Michele DE (2011) The dystrophin-glycoprotein complex in the prevention of muscle damage. J Biomed Biotechnol 2011:210797
Rodriguez MC, Tarnopolsky MA (2003) Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 34:1217–1220
Stolzing A, Scutt A (2006) Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5:213–224
Davies KJA (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301–310
Morel Y, Barouki R (1999) Repression of gene expression by oxidative stress. Biochem J 3:481–496
Kaczor JJ, Hall JE, Payne E, Tarnopolsky MA (2007) Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. Free Radic Biol Med 43:145–154
Lim W, Kim J, Lim C, Kim S, Jeon S, Karna S, Cho M, Choi H, Kim O (2012) Effect of 635 nm light-emitting diode irradiation on intracellular superoxide anion scavenging independent of the cellular enzymatic antioxidant system. Photomed Laser Surg 30:451–459
Rybakova IN, Patel JR, Ervasti JM (2000) The dystrophin complex forms a mechanically strong link between the sarcolemma and Costameric actin. J Cell Biol 150:1209–1214
Leal-Junior EC (2015) Photobiomodulation therapy in skeletal muscle: from exercise performance to muscular dystrophies. Photomed Laser Surg 33:53–54
Acknowledgements
This study received support from São Paulo Research Foundation (FAPESP) for Professor Ernesto Cesar Pinto Leal-Junior (grant number 2010/52404-0) and a PhD scholarship for Gianna Móes Albuquerque-Pontes (grant number 2014/05203-0).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experimental procedures were performed in accordance with the standards of the Brazilian College of Animal Experimentation (COBEA). All experimental protocols were submitted and approved by the Animal Experimentation Ethics Committee of our institution.
The study was conducted in accordance with policies and procedures of Brazilian laws and the Department of Health and Human Services in the USA.
Conflict of interests
Professor Ernesto Cesar Pinto Leal-Junior receives research support from Multi Radiance Medical (Solon, OH, USA), a PBMT device manufacturer. The remaining authors declare that they have no conflict of interests.
Ethical aspects
All experimental protocols were submitted and approved by the Animal Experimentation Ethics Committee of the University of Nove de Julho (UNINOVE) (Protocol AN0008.2014).
Rights and permissions
About this article
Cite this article
Albuquerque-Pontes, G.M., Casalechi, H.L., Tomazoni, S.S. et al. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin. Lasers Med Sci 33, 755–764 (2018). https://doi.org/10.1007/s10103-017-2405-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2405-5